RVX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 42.66%

Insider Buying (Last 12 Months): C$0.00

Insider Selling (Last 12 Months): C$9,000.00

Resverlogix Insider Trading History Chart

Resverlogix Share Price & Price History

C^$0.13

▼ -0.01 (-7.41%)

As of 12/4/2025 12:52 PM ET

Days: 30 | 90 | 365

Resverlogix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/5/2025	Aaron Bradley Cann	Senior Officer	Sell	200,000	C$0.05	C$9,000.00
11/22/2024	Aaron Bradley Cann	Senior Officer	Sell	25,000	C$0.06	C$1,500.00

SEC Filings (Institutional Ownership Changes) for Resverlogix (TSE:RVX)

0.01% of Resverlogix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.

Today's Range

Now: C$0.13

C$0.13

C$0.14

50 Day Range

MA: C$0.10

C$0.09

C$0.14

52 Week Range

Now: C$0.13

C$0.04

C$0.30

Volume

12,213 shs

Average Volume

95,918 shs

Market Capitalization

C$35.92 million

P/E Ratio

N/A

Dividend Yield

7.02%

Beta

0.775273

Who are the company insiders with the largest holdings of Resverlogix?: Resverlogix's top insider investors include:
Aaron Bradley Cann (Senior Officer)
Learn More about top insider investors at Resverlogix.